Z-1233-2026 Class II Ongoing

Recalled by Encore Medical, LP — Austin, TX

FDA device recall Z-1233-2026 was initiated by Encore Medical, LP on Jan 5, 2026 and is designated Class II. Reason for recall: 942-01-40G acetabular system package was found to contain 942-01-36H acetabular system; and several other acetabular system and knee insert devices may also have a packaging discrepancy, which may… The recall status is ongoing. Affected quantity: 19.

Recall details

Product Type
Devices
Report Date
Feb 11, 2026
Initiation Date
Jan 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19

Product description

EMPOWR 3D Knee Tibial Insert 5R 14MM, VE, REF: 342-14-705

Reason for recall

942-01-40G acetabular system package was found to contain 942-01-36H acetabular system; and several other acetabular system and knee insert devices may also have a packaging discrepancy, which may cause surgical delay to exchange devices or revision surgery.

Distribution pattern

US: TX, IA, MI, MS, MA, RI, NJ, PA, NY, MO, OK, PR, AL, CA

Code information

UDI-DI: 00888912167529. Lot: 139T1075A. Expiration: 03-12-2026

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1233-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1233-2026. Report a data issue: hello@regdatalab.com.